> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Joint FDA Panel Looks at Modernizing NDA Assessments
- URL: https://www.fdaweb.com/joint-fda-panel-looks-at-modernizing-nda-assessments/
- Published: 2018-08-14T12:00:00.000Z
- Updated: 2026-09-15T00:25:45.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142099

FDA intends to discuss modernizing its NDA assessments through a “Knowledge-Aided Assessment and Structured Application (KASA)” initiative. At a 9/20 joint Pharmaceutical Science and Clinical Pharmacology Advisory Committee meeting, the agency will seek input on the “potential enhancement of a submission format consistent with KASA to improve the efficiency and consistency of regulatory quality assessment,” a [notice ](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-17524.pdf?ref=fdaweb.com)says. Additionally, the joint committee will discuss in-vitro/in-vivo relationship standards, and it will seek input on establishing patient-focused dissolution standards for oral solid modified-release dosage forms.